摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl erythro-(4R,5S)-2-(5-methyl-4-phenylpyrrolidin-1-yl)acetate | 1301211-93-7

中文名称
——
中文别名
——
英文名称
ethyl erythro-(4R,5S)-2-(5-methyl-4-phenylpyrrolidin-1-yl)acetate
英文别名
ethyl 2-((5S)-methyl-2-oxo-(4R)-phenyl-pyrrolidin-1-yl)acetate;Ethyl 2-((2S,3R)-2-methyl-5-oxo-3-phenylpyrrolidin-1-yl)acetate;ethyl 2-[(2S,3R)-2-methyl-5-oxo-3-phenylpyrrolidin-1-yl]acetate
ethyl erythro-(4R,5S)-2-(5-methyl-4-phenylpyrrolidin-1-yl)acetate化学式
CAS
1301211-93-7
化学式
C15H19NO3
mdl
——
分子量
261.321
InChiKey
YVJURLHORQGZMW-AAEUAGOBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    416.9±45.0 °C(Predicted)
  • 密度:
    1.114±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    19
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.47
  • 拓扑面积:
    46.6
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    ethyl erythro-(4R,5S)-2-(5-methyl-4-phenylpyrrolidin-1-yl)acetate 作用下, 以 甲醇 为溶剂, 反应 5.0h, 以80%的产率得到(4R,5S)-2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)acetamide
    参考文献:
    名称:
    4R,5S-ENANTIOMER OF 2-(5-METHYL-2-OXO-4-PHENYL-PYRROLIDIN-1-YL)-ACETAMIDE WITH NOOTROPIC ACTIVITY
    摘要:
    本发明涉及一种具有高药理学价值的认知增强活性的2-(5-甲基-2-氧代-4-苯基-吡咯烷-1-基)-乙酰胺的5S,4R-对映体及其制备方法,其包括5S-甲基-4R-苯基吡咯烷-2-酮的合成,其与乙酰卤代酸酯的N-烷基化以及中间体乙酰基2-(5S-甲基-2-氧代-4R-苯基-吡咯烷-1-基)-乙酸酯的氨处理。
    公开号:
    US20120215010A1
  • 作为产物:
    描述:
    (3R)-4-nitro-3-phenylpentanoic acid 在 氯化亚砜 、 sodium hydride 作用下, 以 乙醇甲苯 为溶剂, 50.0~120.0 ℃ 、5.07 MPa 条件下, 反应 30.5h, 生成 ethyl erythro-(4R,5S)-2-(5-methyl-4-phenylpyrrolidin-1-yl)acetate
    参考文献:
    名称:
    Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor
    摘要:
    Novel positive allosteric modulators of sigma-1 receptor represented by 2-(5-methyl-4-phenyl-2-oxopyrrolidin-l-yl)-acetamide enantiomers were synthesised using an asymmetric Michael addition of 2-nitroprop-1-enylbenzene to diethyl malonate. Following the chromatographic separation of the methyl erythro- and threo-4-nitro-3R- and 3S-phenylpentanoate diastereoisomers, target compounds were obtained by their reductive cyclisation into 5-methyl-4-phenylpyrrolidin-2-one enantiomers and the attachment of the acetamide group to the heterocyclic nitrogen. Experiments with electrically stimulated rat vas deference contractions induced by the PRE-084, an agonist of sigma-1 receptor, showed that (4R,5S)- and (4R,5R)-2-(5-methyl-4-phenyl-2-oxopyrrolidin-l-yl)-acetamides with an R-configuration at the C-4 chiral centre in the 2-pyrrolidone ring were more effective positive allosteric modulators of sigma-1 receptor than were their optical antipodes. (C) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2013.03.016
点击查看最新优质反应信息

文献信息

  • [EN] 4R,5S-ENANTIOMER OF 2-(5-METHYL-2-OXO-4-PHENYL-PYRROLIDIN-1-YL)-ACETAMIDE WITH NOOTROPIC ACTIVITY<br/>[FR] ENANTIOMÈRE 4R,5S DE 2-(5-MÉTHYL-2-OXO-4-PHÉNYL-PYRROLIDIN-1-YL)-ACÉTAMIDE AYANT UNE ACTIVITÉ NOOTROPIQUE
    申请人:GRINDEKS JSC
    公开号:WO2011054888A1
    公开(公告)日:2011-05-12
    The invention relates to the 5S,4R-enantiomer of 2-(5-methyl-2-oxo-4-phenyl- pyrrolidin-1-yl)-acetamide with cognition enhancing activity of high pharmacological value and to its preparation method which includes the synthesis of 5S-methyl-4R-phenylpyrrolidin-2-one, its N-alkylation with ethyl haloacetate and the treatment of intermediate ethyl 2-(5S-methyl-2-oxo-4R-phenyl-pyrrolidin-1-yl)-acetate with ammonia.
    本发明涉及具有高度药理价值的增强认知活性2-(5-甲基-2-氧代-4-苯基吡咯烷-1-基)乙酰胺的5S,4R-对映体及其制备方法,该方法包括合成5S-甲基-4R-苯基吡咯烷-2-酮,将其与乙基卤代乙酸酯进行N-烷基化,以及用氨处理中间体乙基2-(5S-甲基-2-氧代-4R-苯基吡咯烷-1-基)乙酸酯。
  • US8791273B2
    申请人:——
    公开号:US8791273B2
    公开(公告)日:2014-07-29
  • Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor
    作者:Grigory Veinberg、Maxim Vorona、Liga Zvejniece、Reinis Vilskersts、Edijs Vavers、Edvards Liepinsh、Helena Kazoka、Sergey Belyakov、Anatoly Mishnev、Jevgenijs Kuznecovs、Sergejs Vikainis、Natalja Orlova、Anton Lebedev、Yuri Ponomaryov、Maija Dambrova
    DOI:10.1016/j.bmc.2013.03.016
    日期:2013.5
    Novel positive allosteric modulators of sigma-1 receptor represented by 2-(5-methyl-4-phenyl-2-oxopyrrolidin-l-yl)-acetamide enantiomers were synthesised using an asymmetric Michael addition of 2-nitroprop-1-enylbenzene to diethyl malonate. Following the chromatographic separation of the methyl erythro- and threo-4-nitro-3R- and 3S-phenylpentanoate diastereoisomers, target compounds were obtained by their reductive cyclisation into 5-methyl-4-phenylpyrrolidin-2-one enantiomers and the attachment of the acetamide group to the heterocyclic nitrogen. Experiments with electrically stimulated rat vas deference contractions induced by the PRE-084, an agonist of sigma-1 receptor, showed that (4R,5S)- and (4R,5R)-2-(5-methyl-4-phenyl-2-oxopyrrolidin-l-yl)-acetamides with an R-configuration at the C-4 chiral centre in the 2-pyrrolidone ring were more effective positive allosteric modulators of sigma-1 receptor than were their optical antipodes. (C) 2013 Elsevier Ltd. All rights reserved.
  • 4R,5S-ENANTIOMER OF 2-(5-METHYL-2-OXO-4-PHENYL-PYRROLIDIN-1-YL)-ACETAMIDE WITH NOOTROPIC ACTIVITY
    申请人:Kalvins Ivars
    公开号:US20120215010A1
    公开(公告)日:2012-08-23
    The invention relates to the 5S,4R-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with cognition enhancing activity of high pharmacological value and to its preparation method which includes the synthesis of 5S-methyl-4R-phenylpyrrolidin-2-one, its N-alkylation with ethyl haloacetate and the treatment of intermediate ethyl 2-(5S-methyl-2-oxo-4R-phenyl-pyrrolidin-1-yl)-acetate with ammonia.
    本发明涉及一种具有高药理学价值的认知增强活性的2-(5-甲基-2-氧代-4-苯基-吡咯烷-1-基)-乙酰胺的5S,4R-对映体及其制备方法,其包括5S-甲基-4R-苯基吡咯烷-2-酮的合成,其与乙酰卤代酸酯的N-烷基化以及中间体乙酰基2-(5S-甲基-2-氧代-4R-苯基-吡咯烷-1-基)-乙酸酯的氨处理。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物